[{"id":"23956507-6f6e-456a-86d1-530788914d8c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05410743","created_at":"2022-06-08T11:58:16.092Z","updated_at":"2024-07-02T16:35:09.466Z","phase":"Phase 1","brief_title":"Evaluatioon of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors","source_id_and_acronym":"NCT05410743","lead_sponsor":"The First Affiliated Hospital of Xiamen University","biomarkers":" SSTR • FAP","pipe":" | ","alterations":" SSTR positive • SSTR Expression","tags":["SSTR • FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SSTR positive • SSTR Expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 177Lu-LNC1010"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 06/01/2022","start_date":" 06/01/2022","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-04-16"}]